These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6520229)

  • 41. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Monitoring of interferon therapy by assay of (2'--5') oligo-isoadenylate synthetase in human peripheral white blood cells.
    Schattner A; Merlin G; Wallach D; Rosenberg H; Bino T; Hahn T; Levin S; Revel M
    J Interferon Res; 1981; 1(4):587-94. PubMed ID: 6180091
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Activity of 2, 5-oligoadenylate synthetase in non-A, non-B hepatitis].
    Karino Y; Sugawara T; Saga A; Matsushima T; Miyazaki T
    Nihon Rinsho; 1988 Dec; 46(12):2715-9. PubMed ID: 2468003
    [No Abstract]   [Full Text] [Related]  

  • 44. Monitoring of interferon treatment in patients with renal cell carcinoma and bladder carcinoma by oligo-A synthetase assay and determination of immunological parameters.
    Grups JW; Komprecht B
    J Biol Regul Homeost Agents; 1989; 3(3):98-101. PubMed ID: 2516404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
    Millar BC; Bell JB
    Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.
    Short EC; Fulton RW
    J Clin Microbiol; 1987 Sep; 25(9):1735-40. PubMed ID: 2443533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interferon-induced cytotoxicity and (2'-5') oligo(A) synthetase activity in T cells. Differences in responsiveness among T cells from various individuals and among lymphoblastoid T-cell lines.
    Gazitt Y; Ben-Bassat H; Wallach D; Revel M; Schattner A
    Clin Immunol Immunopathol; 1984 Jan; 30(1):71-9. PubMed ID: 6607796
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Demonstration of 2-5A synthetase in human circulating mononuclear cells after oral administration of an interferon inducer isolated from a fraction of Escherichia coli and Klebsiella pneumoniae].
    Merlin G; Vanderhoven C; Page YM; Falcoff E
    C R Acad Sci III; 1985; 300(17):619-22. PubMed ID: 3939289
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical value of the determination of an interferon-induced enzyme activity: studies of the 2'5' oligoadenylate synthetase activity in peripheral blood lymphocytes of patients.
    Chousterman S; Chousterman M; Reinert P; Thang MN
    Biomed Pharmacother; 1983; 37(4):176-80. PubMed ID: 6198003
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interferon inhibits prostaglandin E2 synthesis and stimulates (2'-5')oligoadenylate synthetase activity in peripheral blood mononuclear cells of inflammatory bowel disease patients.
    Rachmilewitz D; Karmeli F; Panet A
    J Interferon Res; 1985; 5(4):629-35. PubMed ID: 2418132
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated levels of interferon-induced 2'-5' oligoadenylate synthetase in generalized persistent lymphadenopathy and the acquired immunodeficiency syndrome.
    Read SE; Williams BR; Coates RA; Evans WK; Fanning MM; Garvey MB; Shepherd FA
    J Infect Dis; 1985 Sep; 152(3):466-72. PubMed ID: 2411826
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for interferon (IFN) induction in mice and humans by a fraction of bacterial extracts (SLO4) in vitro and after oral administration in vivo.
    Merlin G; Vanderhoven C; Stefanos S; Wietzerbin J; Girard JP; Page Y; Falcoff E
    Antiviral Res; 1985; Suppl 1():161-6. PubMed ID: 3936411
    [No Abstract]   [Full Text] [Related]  

  • 53. 2',5'-oligoadenylate synthetase, neopterin and beta 2-microglobulin in asymptomatic HIV-infected individuals.
    Witt PL; Spear GT; Lindstrom MJ; Kessler HA; Borden EC; Phair J; Landay AL
    AIDS; 1991 Mar; 5(3):289-93. PubMed ID: 2059368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Decreased interferon binding capacity of peripheral blood mononuclear cells during interferon treatment of chronic hepatitis B with special reference to (2'-5') oligoadenylate synthetase activity.
    Shindo M; Iwata A; Okuno T; Matsumoto M; Takeda M; Arai K; Sokawa Y
    Gastroenterol Jpn; 1989 Dec; 24(6):670-5. PubMed ID: 2481600
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 2',5' Oligoadenylate synthetase activity in peripheral blood mononuclear cells and serum during interferon treatment of chronic non-A, non-B hepatitis.
    Okuno T; Shindo M; Arai K; Matsumoto M; Takeda M; Kashima K; Sokawa Y
    Gastroenterol Jpn; 1991 Oct; 26(5):603-10. PubMed ID: 1752391
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2',5'-Oligoadenylate synthetase activity in peripheral blood lymphocytes as a clinical marker in interferon therapy for chronic hepatitis B.
    Furuta M; Akashi K; Nakamura Y; Matsumoto K; Yamaguchi H; Takamatsu S; Shimizu T
    J Interferon Res; 1987 Feb; 7(1):111-9. PubMed ID: 3585079
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [2'-5' olygoadenylate synthetase activity in peripheral facial paralysis].
    Nakazato H; Ikeda M
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Mar; 98(3):457-64. PubMed ID: 7738709
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting responses to interferon.
    Lancet; 1990 Dec; 336(8727):1388-9. PubMed ID: 1978206
    [No Abstract]   [Full Text] [Related]  

  • 59. [Evaluation of 2,5-oligoadenylate synthetase and protein kinase activities in clinical studies of larifan and recombinant interferon alpha in volunteers].
    Sokolova TM; Nosik NN; Lopatina OA; Krylov VF
    Antibiot Khimioter; 1991 Jul; 36(7):42-5. PubMed ID: 1953190
    [TBL] [Abstract][Full Text] [Related]  

  • 60. CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep.
    Nichani AK; Kaushik RS; Mena A; Popowych Y; Dent D; Townsend HG; Mutwiri G; Hecker R; Babiuk LA; Griebel PJ
    Cell Immunol; 2004 Jan; 227(1):24-37. PubMed ID: 15051512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.